跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZOLDONAT CONCENTRATE FOR SOLUTION FOR INFUSION 4 MG/5 ML - HSA Drug Approval Details
Approvals
/
HSA
/
ZOLDONAT CONCENTRATE FOR SOLUTION FOR INFUSION 4 MG/5 ML
Approved
THERAPEUTIC
ZOLDONAT CONCENTRATE FOR SOLUTION FOR INFUSION 4 MG/5 ML
Gland Pharma Limited (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Jul 29, 2016
Approval ID
a682de642117908e
Company
Gland Pharma Limited (INDIA)
Type
Therapeutic
Approval Details
Approval Id
a682de642117908e
Drug Name
ZOLDONAT CONCENTRATE FOR SOLUTION FOR INFUSION 4 MG/5 ML
Product Name
ZOLDONAT CONCENTRATE FOR SOLUTION FOR INFUSION 4 MG/5 ML
Approval Number
SIN15057P
Approval Date
2016-07-29
Registrant
NATCO PHARMA ASIA PTE. LTD.
Licence Holder
NATCO PHARMA ASIA PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION, CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
M05BA08
Atc Item Name
zoledronic acid
Pharma Manufacturer Name
NATCO PHARMA ASIA PTE. LTD.
Active Ingredients
Zoledronic Acid Monohydrate 4.264 mg EQV Zoledronic Acid
4 mg
ZOLEDRONIC ACID MONOHYDRATE 4.264 MG EQV ZOLEDRONIC ACID
4 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 29, 2016
Approval ID
a682de642117908e
Type
Therapeutic
Back to HSA Approvals
